Fri. March 19, 2010
-
PhysOrg.com
March 19, 2010
Virtually all (94%) of the scientific
authors who provided positive results for the anti-diabetic drug
rosiglitazone had financial relationships with ...
FiercePharma
March 19, 2010
After
GlaxoSmithKline's
diabetes drug
Avandia was linked to heart disease in May 2007, a fierce debate ensued, with much of it played out in scholarly ...
BusinessWeek
March 18, 2010
Lawyers and Settlements
March 16, 2010
Philadelphia, PA: International pharmaceutical manufacturer
GlaxoSmithKline (GSK) could face as much $6 billion in liability lawsuits stemming from
Avandia ...
U.S. News & World Report
March 15, 2010
... chairman of the department of cardiovascular medicine at the Cleveland Clinic, whose research linked the
diabetes drug
Avandia with an increased rate of ...
Daily News & Analysis
March 15, 2010
With the FDA now reviewing
Avandia to assess heart risks, several medical practioners are switching over to
Actos. The basic patent for the drug expires in ...
Huffington Post (blog)
March 15, 2010
... that "given that other [treatment] options are now recommended, the consensus group members unanimously advised against using
rosiglitazone [
Avandia]. ...
Seeking Alpha (blog)
March 15, 2010
According to the Senate report, FDA
scientists estimated in July 2007 that
Avandia was associated with approximately 83000 heart attacks since the drug came ...
In Jersey (blog)
March 13, 2010
If you are diabetic and taking
Avandia please meet with your
physician ASAP to check out your heart health. Since the release of
Avandia it's manufacturer ...
Science News
March 12, 2010
Raw data from the combined trials showed that only 55 people in 10000 had heart attacks when using Avandia, compared with 59 people per 10000 in comparison ...
Newsome Law (blog)
March 12, 2010
the US Senate Finance Committee also released a report prior to the UBS announcement about the dangers associated with
Avandia, as well as the more than ...
7thSpace Interactive (press release)
March 12, 2010
We also established that rosiglitazone (a PPARgamma agonist) elevated MKP-1 expression level in NSCLC cells and inhibited tumour metastasis. ...
DTC Perspectives Magazine
March 12, 2010
The search for drug company evil continues as
Glaxo's
Avandia is the latest drug in the crosshairs of regulators, the media and lawyers. ...
Forbes (blog)
March 11, 2010
Justice News Flash
March 11, 2010
... who was president of the American College of Cardiology in 2007, reportedly announced that based on his evaluation of
Avandia (
rosiglitazone), ...
PR-USA.net (press release)
March 10, 2010
The drug
Avandia (
rosiglitazone) was introduced to the
market in 1999 as an anti-diabetic medication which improves blood sugar control by directly ...
Newsinferno.com
March 10, 2010
Liability for
Avandia lawsuits could total as much as $6 billion, according to a UBS
analyst.
GlaxoSmithKline, the maker of
Avandia, faces more than 13000 ...
Newsinferno.com
March 9, 2010
Liability for
Avandia lawsuits could total as much as $6 billion, according to a UBS
analyst.
GlaxoSmithKline, the maker of
Avandia, faces more than 13000 ...
AboutLawsuits.com
March 8, 2010
Avandia (
rosiglitazone) was approved by FDA in 1998 to treat type 2
diabetes by helping control blood sugar levels. The drug has been used by millions of ...
Houma Courier
March 7, 2010
Also, the Food and Drug Administration added warnings about increased risk of heart attacks linked to the popular
diabetes drug
Avandia. ...
Philadelphia Inquirer
March 6, 2010
Linda Loyd
GlaxoSmithKline PLC could be facing liabilities of up to $6 billion from 13000 personal-injury lawsuits relating to its
diabetes drug
Avandia, ...
Daily News & Analysis
March 6, 2010
A study published in the 'New
England Journal of Medicine' then found that
Avandia (brand name for
rosiglitazone in US) puts users at a 60% greater risk of ...
A Sweet Life (blog)
March 6, 2010
The next group received
rosiglitazone (
Avandia) in addition to their current therapy (let's call them the RSG group). Group 3 exercised in addition to ...
CanadianBusiness.com
March 5, 2010
London (AP) -
GlaxoSmithKline PLC could be facing liabilities up to $6 billion over personal injury lawsuits relating to its
diabetes drug
Avandia, ...
The Age
March 5, 2010
Because of safety concerns about other drugs such as
Avandia, for
diabetes, the TGA should invest at least $5 million a year into safety research to ...
The IN VIVO Blog (blog)
March 5, 2010
In the "History of Troubled Drugs" playbook, lumiracoxib (Prexige, now called Joicela) is only a footnote, hardly a Vioxx or Avandia. ...
Independent
March 5, 2010
"As US
Avandia contributes 1 per cent to sales, our concerns are solely on personal injury lawsuits," the
broker said. "The experts we polled suggest GSK's ...
BusinessWeek
March 5, 2010
GlaxoSmithKline PLC could be facing liabilities up to $6 billion over personal injury lawsuits relating to its
diabetes drug
Avandia, UBS
analysts said in a ...
Lawyers and Settlements
March 4, 2010
San Jose, CA: Things seem to be going from bad to worse for the makers of
Avandia. Late last week Santa Clara County in
California filed suit against ...
Newswise (press release)
March 3, 2010
Sanjay Kaul, MD co-authored the advisory about drugs called thiazolidinediones (TZDs) such as pioglitazone (
Actos) or
rosiglitazone (
Avandia). ...
Seeking Alpha (blog)
March 3, 2010
Two US Food and Drug Administration safety reviewers have recommended that
GlaxoSmithKline (GSK)
diabetes drug
Avandia be pulled from the
market because it ...
Gerson Lehrman Group
March 3, 2010
There are no prospective randomized, controlled trials of
Avandia and
Actos, and we're glad the
science advisory called for clinicians to demand more ...
Korea Times
March 3, 2010
Avandia was subject to a safety alert over possible association between its main substance,
rosiglitazone, and increased cardiovascular risks, ...
Trading Markets (press release)
March 3, 2010
A Senate report released over the weekend questioned the safety of
Avandia, linking it to elevated heart risks and alleging that
GlaxoSmithKline underplayed ...
Corporate Counsel
March 3, 2010
TheHeart.Org
March 2, 2010
This trial, comparing
rosiglitazone vs pioglitazone in people with type 2
diabetes, has recently been in the news in the wake of new calls for
rosiglitazone ...
AboutLawsuits.com
March 2, 2010
Avandia (
rosiglitazone) is a thiazolidinedione agent, a class of drugs approved by FDA in 1998 to treat type 2
diabetes by helping control blood sugar ...
A Sweet Life (blog)
February 28, 2010
... age 66 or older who had been prescribed either
Actos (pioglitazone) or
Avandia (
rosiglitazone) and followed their medical records for a number of years. ...
U.S. News & World Report (blog)
February 27, 2010
The Food and Drug Administration is scrutinizing the safety of
diabetes drug
Avandia, as concerns about its heart risks are swirling ...
U.S. News & World Report (blog)
February 26, 2010
The Food and Drug Administration is scrutinizing the safety of
diabetes drug
Avandia, as concerns about its heart risks are swirling ...
